An open-label, multicenter, noncomparative safety and efficacy study of Mircette(TM), a low-dose estrogen-progestin oral contraceptive

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 1, 1998, Pages

  Akin, M ^a   Archer, D ^a   Berga, S ^a   Burns, L ^a   Calkins, J ^a   Davis, A ^a   Draeger, M ^a   Freidensen, H ^a   Funk, S ^a   Giesler, C ^a   Gordon, S ^a   Katz, D ^a   Khairi, S ^a   Ledger, W ^a   Lenihan, J ^a   London, R ^a   McQuarrie, H ^a   Medina, H ^a   Mercer, L ^a   Milhalov, L ^a   Montgomery, M ^a   Notelovitz, M ^a   Parker, G ^a   Phillips, E ^a   Reza, L ^a   San Fillippo, J ^a   Saxena, B ^a   Singh, M ^a   Soltes, B ^a   Soper, H ^a   Speroff, L ^a   Summers, P ^a   Trupin, S ^a   Weissberg, S ^a   Willems, J ^a   Young, R ^a   more..

^a Pharmaco International Inc   (United States)

Author keywords

Desogestrel; Ethinyl estradiol; Mircette(TM); Oral contraceptives

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; LOW DOSE ORAL CONTRACEPTIVE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MASTALGIA; MENSTRUAL CYCLE; MENSTRUATION DISORDER; MULTICENTER STUDY; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPOTTING; VAGINA BLEEDING;

EID: 0031856274     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70290-X     Document Type: Article

References (19)

1. RT. Burkman The estrogen component of OCs: cardiovascular benefits and risks Int J Fertil 42 suppl 1 1997 145 157
2. MJ Rosenberg SC. Long Oral contraceptives and cycle control: a critical review of the literature Adv Contracept 8 suppl 1 1992 35 45
3. AM. Kaunitz Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile Am J Obstet Gynecol 168 1993 1028 1033
4. B. Kaplan Desogestrel, norgestimate, and gestodene: the newer progestins Ann Pharmacother 29 1995 736 742
5. P Bilotta S. Favilli Clinical evaluation of monophasic ethinyl estradiol/desogestrel containing oral contraceptives Arzneimittelforschung 38 1988 932 934
6. P Lammers M op ten Berg Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinyl estradiol Acta Obstet Gynecol Scand 70 1991 497 500
7. K Fotherby Clinical experience and pharmacological effects of an oral contraceptive containing 20 μg oestrogen Contraception 46 1992 477 488
8. M Mall-Haefeli I Werner-Zodrow PR Huber A. Edelman Oral contraception and ovarian function B Runnebaum T Rabe L Kiesel Female contraception. 1988 Springer-Verlag Berlin 97 105
9. J Spona W Feichtinger C Kindermann C Wünsch K Brill Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinyl estradiol Contraception 54 1996 299 304
10. AT Teichmann K Brill M Albring J Schnitker P Wojtynek E. Kustra The influence of the dose of ethinyl estradiol in oral contraceptives on follicle growth Gynecol Endocrinol 9 1995 299 305
11. SA Killick C Fitzgerald A Davis Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel: effects of low estrogen doses during the hormone-free interval Am J Obstet Gynecol 179 1998 S18 S24
12. PJ Sulak BE Cressman E Waldrop S Holleman J. Kuehl Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms Obstet Gynecol 89 1997 179 183
13. Organon Desogen package insert 1996 Organon Inc West Orange, (NJ) Copyright
14. K Brill J Schnitker M. Albring Long-term experience with a low-dose oral contraceptive Gynecol Endocrinol 4 1990 277 286
15. K Brill T Norpoth J Schnitker M. Albring Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users Contraception 43 1991 101 110
16. S Berga Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette™ Am J Obstet Gynecol 179 1998 S9 S17
17. K Fotherby ADS. Caldwell The new low dose oral contraceptives Br J Obstet Gynecol 14 1994 327 332
18. GA Hill JM. Wheeler Incidence of breakthrough bleeding during oral contraceptive therapy J Reprod Med 36 4 suppl 1991 334 339
19. RF Casper AM. Powell Evaluation and therapy of breakthrough bleeding in women using a triphasic oral contraceptive Fertil Steril 55 1991 292 296